Difference between revisions of "Anticancer.de"
(migration import) |
(auto generate) |
||
| Line 76: | Line 76: | ||
[[Category:Antisense]] | [[Category:Antisense]] | ||
[[Category:TGFbeta]] | [[Category:TGFbeta]] | ||
| + | <div id='domainResolution'></br> | ||
| + | === Domain Resolution === | ||
| + | This domain resolves to the following IP addresses:</br><ul><li><a href="/Special:WhatsMyIpAddress/54.72.9.51">54.72.9.51</a></li></ul></div> | ||
Latest revision as of 13:55, 6 April 2014
Title
Krebsstudien [Antisense Pharma GmbH]: Home
Description
Excerpted from the website description:
- This website provides information for cancer patients, physicians and others interested in clinical studies with antisense drugs.
Languages
English
Additional Information
Related Domains
External Links
Domain Resolution
This domain resolves to the following IP addresses:
Categories:
- AP12009
- Aggressive Tumors
- Anaplastic Astrocytoma
- Anti Sense
- Anticancer Treatment
- Antisense Drugs
- Antisense Pharma
- Antisense Study
- Antisense Technology
- Award
- Bavaria
- Biotechnology
- Brain Tumor
- Cancer
- Cancer Drug
- DNA
- Exclusion Criteria
- Founders Award
- Glioblastoma
- Glioma
- Inclusion Criteria
- Innovation
- Malignant
- Multimodal
- Neurooncology
- Oligonucleotide
- Oncology
- Phase I
- Phase II
- Phase III
- Protein
- RNA
- Regensburg
- Schlingensiepen
- Study Centers
- Systemic
- TGF-b
- TGF-beta
- TGF Beta
- Targeted
- Therapy
- Transforming Growth Factor
- Trial Sites
- Tumor
- Antisense
- TGFbeta